Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C3AR1 | Q16581 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | PDE4A | P27815 | 3/20 | 0.46 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.46 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.46 |
| ▸ | PADI1 | Q9ULC6 | 2/20 | 0.46 |
| ▸ | PADI4 | Q9UM07 | 2/20 | 0.46 |
| ▸ | PADI2 | Q9Y2J8 | 2/20 | 0.46 |
| ▸ | PADI6 | Q6TGC4 | 1/20 | 0.46 |
| ▸ | PADI3 | Q9ULW8 | 1/20 | 0.46 |
| ▸ | ACE | P12821 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7263139 | 0.91 | HPGD (0.49) | C3AR1CA2HPGDACEALDH1A1 | |
| SCHEMBL28409793 | 0.88 | NAALAD2 (0.45) | C3AR1CA2HPGDPDE4AACE | |
| SCHEMBL22856661 | 0.87 | FOLH1 (0.54) | C3AR1CA2HPGDALDH1A1CTSL | |
| SCHEMBL16448204 | 0.83 | LMNA (0.56) | HPGDPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL16448110 | 0.83 | TGM2 (0.48) | ALDH1A1TSHR | |
| SCHEMBL16448107 | 0.83 | TGM2 (0.48) | ALDH1A1TSHR | |
| SCHEMBL16150251 | 0.83 | KDM1A (0.58) | CA2PADI4PADI6CA1CTSL | |
| SCHEMBL16150248 | 0.83 | KDM1A (0.58) | CA2PADI4PADI6CA1CTSL | |
| SCHEMBL16448206 | 0.83 | LMNA (0.56) | HPGDPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL11670630 | 0.82 | CAPN1 (0.47) | HPGDALDH1A1CYP1A2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7671231-B2 | L-allysine acetal prepared by contacting a 2-butene acetal with a hydroformylation catalyst and synthesis gas to prepare aldehyde mixture; contacting with an enantioselective hydrolase in the presence of water and hydrocyanic acid/ammonia; separation from branched derivatives | LLOYD MICHAEL C | 2010-03-02 | — | — | US | disclosed |
| US-20070166806-A1 | Process for making amino acids | LLOYD MICHAEL C | 2007-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070166806-A1 | Process for making amino acids | DDC, ALDH7A1, ASPH | C3AR1 1300/4885CA2 496/4885HPGD 357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.